ANG-2 WEBINARS - GLOBAL

MODERATOR’S OPENING

Dr. William Li is the CEO and co-founder of the Angiogenesis Foundation where he leads national and international efforts to develop new therapeutic strategies for disease involving the microvasculature, including retinopathy.   Dr. Li has authored more than 100 publications including a New York Times Bestseller.

William Li, MD
The Angiogenesis Foundation

PRESENTATION 1

Charles Wykoff MD, PhD
Retina Consultants of Texas, Houston, TX

Dr. Charles Wykoff is a world-renowned ophthalmologist with the Retina Consultants of Texas; He’s Chairman of the Research and Clinical Trials Committee for the Retina Consultants of America; and Deputy Chair of Ophthalmology for the Blanton Eye Institute, Houston Methodist Hospital. He has published over 200 peer-reviewed manuscripts and is a frequent speaker at national and international academic meetings. His research interests pertain to angiogenesis, retinal vascular diseases, atrophic retinal diseases, and vitreoretinal surgical topics.

PRESENTATION 2

Dr. David Eichenbaum serves as Director of Research for the Retina Vitreous Associates of Florida.  He is a highly published researcher and clinician, and a leading clinical investigator in over 70 clinical trials with a focus on neovascular retinal diseases.

David Eichenbaum, MD

Retina Vitreous Associates, St. Petersburg, FL

PRESENTATION 3

Dr. Charles Wykoff is a world-renowned ophthalmologist with the Retina Consultants of Texas; He’s Chairman of the Research and Clinical Trials Committee for the Retina Consultants of America; and Deputy Chair of Ophthalmology for the Blanton Eye Institute, Houston Methodist Hospital. He has published over 200 peer-reviewed manuscripts and is a frequent speaker at national and international academic meetings. His research interests pertain to angiogenesis, retinal vascular diseases, atrophic retinal diseases, and vitreoretinal surgical topics.

Charles Wykoff MD, PhD

Retina Consultants of Texas, Houston, TX

PANEL DISCUSSION

  • Christina Weng, MD, MBA

    Baylor College of Medicine, Houston, Texas

    Dr. Weng hails from Texas, where she is an Associate Professor of Ophthalmology, and the Vitreoretinal Diseases & Surgery Fellowship Program Director at the Baylor College of Medicine in Houston, Texas. She also has a faculty appointment at the Level 1 trauma center at Ben Taub General Hospital. Dr. Weng is currently involved in multiple clinical trials, including some focused on diabetic retinopathy and subretinal gene therapy for achromatopsia.

  • Nancy Holekamp, MD

    Pepose Vision Institute

    Dr. Holekamp is the Director of Retina Services at the Pepose Vision Institute in St. Louis, Missouri. She has been a principal investigator in more than 38 national clinical trials dealing with age-related macular degeneration, retinal vascular occlusion, and diabetic retinopathy.  Her research efforts have resulted in 80 peer-reviewed publications, 22 book chapters, and more than 125 speaking invitations.

  • Jennifer Lim, MD

    University of Illinois at Chicago

    Dr. Lim holds the Marion H. Schenk Esq., Chair in Ophthalmology for Research in the Aging Eye as Professor of Ophthalmology and is the Vice Chair for Diversity and Inclusion and Director of the Retina Service at University of Illinois at Chicago. She has been the principal investigator in over 60 clinical trials, and currently serves on several Data and Monitoring Committees. She has been actively involved in clinical trials for AMD, diabetic retinopathy, vein occlusion and PVR, and also served on the NEC for the faricimab trials.

  • William Li, MD

    Angiogenesis Foundation

    Dr. William Li is the CEO and co-founder of the Angiogenesis Foundation where he leads national and international efforts to develop new therapeutic strategies for disease involving the microvasculature, including retinopathy.   Dr. Li has authored more than 100 publications including a New York Times Bestseller.